NCT00692627

Brief Summary

acidosis, acute renal failure and acute pulmonary oedema are common, and frequently fatal, manifestations of severe P. falciparum malaria. The course of all three might be ameliorated by optimising a patient's intravenous fluid therapy. The fluid treatment of severe malaria is presently empirical, by defining cardiovascular responses to volume replacement we would provide a physiological basis for resuscitation strategies. We will use pulse contour cardiac output monitoring (PiCCOTM) to guide the fluid resuscitation of patients admitted to intensive care with severe malaria. With data collected during the patients' admission we hope to:

  1. 1.Assess the degree of hypovolaemia in adults with severe malaria and its contribution to microcirculatory dysfunction and acidosis.
  2. 2.To assess the relationships between volume status, haemodynamic parameters and the renal and pulmonary manifestations of severe malaria.
  3. 3.To assess the utility of central venous pressure measurement as a guide for fluid administration in patients with severe malaria
  4. 4.To investigate the prognostic and clinical utility of central venous oxygen saturation in severe malaria

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2008

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 6, 2008

Completed
25 days until next milestone

Study Start

First participant enrolled

July 1, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

January 22, 2015

Status Verified

January 1, 2010

Enrollment Period

5 months

First QC Date

June 3, 2008

Last Update Submit

January 21, 2015

Conditions

Keywords

Falciparummalariavolumehaemodynamics

Outcome Measures

Primary Outcomes (1)

  • Metabolic Acidosis

    48 hours

Secondary Outcomes (2)

  • Acute renal failure

    By discharge

  • Acute pulmonary oedema

    By discharge

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Severe Falciparum Malaria

You may qualify if:

  • Severe malaria, defined by the modified criteria of Hien et al and the presence of asexual forms of P. falciparum in the peripheral blood smear.
  • The patients or their attending relative able and willing to give fully informed written consent.
  • Age ≥ 16 years

You may not qualify if:

  • \. Patients or relatives unable or unwilling to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chittagong Medical College Hospital

Chittagong, Bangladesh

Location

Related Publications (1)

  • Hanson J, Lam SW, Alam S, Pattnaik R, Mahanta KC, Uddin Hasan M, Mohanty S, Mishra S, Cohen S, Day N, White N, Dondorp A. The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study. Malar J. 2013 Oct 1;12:348. doi: 10.1186/1475-2875-12-348.

MeSH Terms

Conditions

Malaria, FalciparumMalaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Arjen Dondorp, MD

    Mahidol Oxford Tropical Medicine Research Unit

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 3, 2008

First Posted

June 6, 2008

Study Start

July 1, 2008

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

January 22, 2015

Record last verified: 2010-01

Locations